These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 12089954)

  • 21. Role of parathyroid hormone and therapy with active vitamin D sterols in renal osteodystrophy.
    Hernandez JD; Wesseling K; Salusky IB
    Semin Dial; 2005; 18(4):290-5. PubMed ID: 16076350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renal bone diseases in children treated with dialysis.
    Sanchez CP; Salusky IB
    Adv Ren Replace Ther; 1996 Jan; 3(1):14-23. PubMed ID: 8620364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal osteodystrophy: review of the disease and its treatment.
    El-Kishawi AM; El-Nahas AM
    Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):373-82. PubMed ID: 16970258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Renal osteodystrophy Guidelines].
    Messa P;
    G Ital Nefrol; 2003; 20 Suppl 24():S83-95. PubMed ID: 14666505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients].
    Okada N; Tsubakihara Y
    Clin Calcium; 2004 May; 14(5):698-706. PubMed ID: 15577030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of renal bone disease.
    Ferreira A
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():2-12. PubMed ID: 16884393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal osteodystrophy.
    Dabbagh S
    Curr Opin Pediatr; 1998 Apr; 10(2):190-6. PubMed ID: 9608898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy for ROD and measurement of the bone mass].
    Yamamoto I; Kawamura Y; Hirano K; Hayakawa H; Shigematu T
    Clin Calcium; 2004 Dec; 14(12):83-8. PubMed ID: 15577179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic kidney disease-mineral and bone disorder (CKD-MBD)].
    Hamada Y; Fukagawa M
    Nihon Rinsho; 2006 Sep; 64(9):1703-6. PubMed ID: 16972683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P
    APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of new markers of bone metabolism in renal osteodystrophy in children].
    Deschenes G; Souberbielle JC; Brunelle F; Dechaux M
    Ann Pediatr (Paris); 1990 Feb; 37(2):120-2. PubMed ID: 2181914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secondary hyperparathyroidism in chronic renal failure.
    Wills MR; Savory J
    Ann Clin Lab Sci; 1981; 11(3):252-61. PubMed ID: 6264838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of calcium and phosphorus in hemodialysis.
    Goldsmith RS
    Annu Rev Med; 1976; 27():181-90. PubMed ID: 180871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PTH(1-84)/PTH(7-84): a balance of power.
    Friedman PA; Goodman WG
    Am J Physiol Renal Physiol; 2006 May; 290(5):F975-84. PubMed ID: 16601298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.
    Torres PU
    J Ren Nutr; 2006 Jul; 16(3):253-8. PubMed ID: 16825031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in the management of renal osteodystrophy in children.
    Salusky IB; Ramirez JA; Goodman WG
    Curr Opin Nephrol Hypertens; 1993 Jul; 2(4):580-7. PubMed ID: 7859020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.